# Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)

> **NCT05962541** · PHASE4 · RECRUITING · sponsor: **University of Roma La Sapienza** · enrollment: 327 (estimated)

## Conditions studied

- Non-muscle-invasive Bladder Cancer
- Non-Muscle Invasive Bladder Urothelial Carcinoma
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

## Interventions

- **DRUG:** PDD-TURBT with hexaminolevulinate (Hexvix®)
- **DEVICE:** Power Led Saphira (TM)

## Key facts

- **NCT ID:** NCT05962541
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-22
- **Primary completion:** 2028-12
- **Final completion:** 2031-12
- **Target enrollment:** 327 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05962541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05962541, "Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05962541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*